AK

Ashwani Kumar Tejpal

Active Director Director DIN 07789379
DIN 07789379 First appointment Apr 2017 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 1 historical roles
Total affiliations 4 Since Apr 2017
Shareholding value •••• Premium profile

About Ashwani Kumar Tejpal

Data last updated:

Ashwani Kumar Tejpal is a Director at Uniphar Biotech Private Limited (since 2017), Director at Abiz Pharma Private Limited (since 2018) and Director at Logimed Pharma Private Limited (since 2017). The companies operate in Pharma and Business Services. The 3 current companies with reported revenue have a combined latest revenue of ₹7.84 Cr; the largest is Uniphar Biotech Private Limited at ₹4.85 Cr (FY 2024). Earlier, Ashwani Kumar Tejpal was a Director at Arovea Lifesciences Private Limited (2018–2021).

DIN 07789379
Primary Designation Director
Industry Pharma
First Appointment 12 Apr 2017
Oldest Company Age 13 yrs
Largest company Uniphar Biotech Private Limited · ₹4.85 Cr (FY 2024)
Combined revenue ₹7.84 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Uniphar Biotech Private Limited U24232CH2013PTC034725
Director12 Apr 20172013₹4.85 Cr (FY 2024)Active
Abiz Pharma Private Limited U74999CH2018PTC041860
Director13 Feb 20182018₹2.18 Cr (FY 2025)Active
Logimed Pharma Private Limited U24232CH2015PTC035450
Director12 Apr 20172015₹80.2 Lakh (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arovea Lifesciences Private Limited U74999HR2018PTC076118
Director28 Sep 20182018Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Uniphar Biotech Private Limited
Logimed Pharma Private Limited
Abiz Pharma Private Limited
Arovea Lifesciences Private Limited
Premium access

Shareholding and investment profile for Ashwani Kumar Tejpal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashwani Kumar Tejpal

Ashwani Kumar Tejpal currently holds 3 directorships: Uniphar Biotech Private Limited (Director, since 12 Apr 2017, revenue ₹4.85 Cr (FY 2024)); Abiz Pharma Private Limited (Director, since 13 Feb 2018, revenue ₹2.18 Cr (FY 2025)); Logimed Pharma Private Limited (Director, since 12 Apr 2017, revenue ₹80.2 Lakh (FY 2024)).

Ashwani Kumar Tejpal was first appointed on 12 Apr 2017 as Director at Uniphar Biotech Private Limited. The most recent appointment on record is 28 Sep 2018 at Arovea Lifesciences Private Limited.

The 3 current companies of Ashwani Kumar Tejpal that report revenue have a combined latest revenue of ₹7.84 Cr: Uniphar Biotech Private Limited ₹4.85 Cr (FY 2024); Abiz Pharma Private Limited ₹2.18 Cr (FY 2025); Logimed Pharma Private Limited ₹80.2 Lakh (FY 2024).

Ashwani Kumar Tejpal held 1 earlier board appointment: Arovea Lifesciences Private Limited (Director, 28 Sep 2018 to 10 Feb 2021).

The current boards of Ashwani Kumar Tejpal's companies include Adesh Saini (Uniphar Biotech Private Limited), Kamna Matta (Uniphar Biotech Private Limited), Rajeev Matta (Uniphar Biotech Private Limited), Vinay Chadha (Logimed Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available